Treata Pharmaceuticals

Treata is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products

Products

Treata develops and acquires best-in-class products for unmet medical needs

Pipeline

Phase III studies are underway for two Treata product candidates

Investor
Presentation

Stock
Information

Financial
Reports

Corporate Governance

Recent News
Mar. 18, 2025

Treata Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results

Mar. 11, 2025

Treata Pharmaceuticals Schedules Q4 & Fiscal 2024 Earnings Release and Conference Call

See more releases
Our team is continually evaluating businesses with commercial products, proven capabilities or where synergies exist with our current product offerings for merger or acquisition opportunities
Business Development
Click Here

©2025 Treata Pharma Corporation
All Rights Reserved.

Treata Pharma Corporation
170 University Avenue, Suite 602
Toronto, ON M5H 3B3
Phone: (905) 693-8285